Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan

被引:0
作者
Taku Aoki
Norihiro Kokudo
Izumi Komoto
Kyoichi Takaori
Wataru Kimura
Keiji Sano
Takeshi Takamoto
Takuya Hashimoto
Takuji Okusaka
Chigusa Morizane
Tetsuhide Ito
Masayuki Imamura
机构
[1] The University of Tokyo,Hepato
[2] The University of Tokyo,Biliary
[3] Kansai Electric Power Company Hospital,Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
[4] Kyoto University,Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine
[5] Yamagata University Faculty of Medicine,Department of Surgery
[6] Teikyo University School of Medicine,Department of Hepatobiliary
[7] Japanese Red Cross Medical Center,Pancreatic Surgery and Transplantation, Graduate School of Medicine
[8] National Cancer Center Hospital,Department of Gastroenterological, Breast, Thyroid, and General Surgery
[9] Kyushu University,Department of Surgery
来源
Journal of Gastroenterology | 2015年 / 50卷
关键词
Neuroendocrine tumors; Streptozocin; Multi-center survey; Tumor response; Progression-free survival rate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:769 / 775
页数:6
相关论文
共 43 条
[1]  
Yao JC(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the US J Clin Oncol 26 3063-3072
[2]  
Hassan M(2008)Neuroendocrine tumor epidemiology: contrasting Norway and North America Cancer 113 2655-2664
[3]  
Phan A(2010)Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan J Gastroenterol 45 234-243
[4]  
Hauso O(2014)Recommendations for management of patients with neuroendocrine liver metastases Lancet Oncol 15 e8-e21
[5]  
Gustafsson BI(1980)Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma N Engl J Med 303 1189-1194
[6]  
Kidd M(1992)Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma N Engl J Med 326 519-523
[7]  
Ito T(1998)Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma Am J Clin Oncol 21 36-38
[8]  
Sasano H(1988)Prospective study of chemotherapy in patients with metstatic gastrinoma Gastroenterology 94 1326-1334
[9]  
Tanaka M(1990)Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors Cancer 65 1883-1890
[10]  
Frilling A(1999)Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma Cancer 86 944-948